Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP437233.RAu_JzWjaqR26-4vQkB50bESgJNhm3qtHHHepFJ9I3rAI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP437233.RAu_JzWjaqR26-4vQkB50bESgJNhm3qtHHHepFJ9I3rAI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP437233.RAu_JzWjaqR26-4vQkB50bESgJNhm3qtHHHepFJ9I3rAI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP437233.RAu_JzWjaqR26-4vQkB50bESgJNhm3qtHHHepFJ9I3rAI130_provenance.
- befree-20150227 importedOn "2015-02-27" NP437233.RAu_JzWjaqR26-4vQkB50bESgJNhm3qtHHHepFJ9I3rAI130_provenance.
- NP437233.RAu_JzWjaqR26-4vQkB50bESgJNhm3qtHHHepFJ9I3rAI130_assertion wasGeneratedBy ECO_0000203 NP437233.RAu_JzWjaqR26-4vQkB50bESgJNhm3qtHHHepFJ9I3rAI130_provenance.
- NP437233.RAu_JzWjaqR26-4vQkB50bESgJNhm3qtHHHepFJ9I3rAI130_assertion wasDerivedFrom befree-20150227 NP437233.RAu_JzWjaqR26-4vQkB50bESgJNhm3qtHHHepFJ9I3rAI130_provenance.
- NP437233.RAu_JzWjaqR26-4vQkB50bESgJNhm3qtHHHepFJ9I3rAI130_assertion SIO_000772 12091121 NP437233.RAu_JzWjaqR26-4vQkB50bESgJNhm3qtHHHepFJ9I3rAI130_provenance.
- NP437233.RAu_JzWjaqR26-4vQkB50bESgJNhm3qtHHHepFJ9I3rAI130_assertion evidence source_evidence_literature NP437233.RAu_JzWjaqR26-4vQkB50bESgJNhm3qtHHHepFJ9I3rAI130_provenance.
- NP437233.RAu_JzWjaqR26-4vQkB50bESgJNhm3qtHHHepFJ9I3rAI130_assertion description "[This protective effect mediated by the presence of GSTM1 was even more pronounced within the subset of therapy group B patients at highest clinical risk of treatment failure (B-ALL, disease stage IV, disease stage III with unresected abdominal tumor, and LDH activity > or = 500 U/L).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP437233.RAu_JzWjaqR26-4vQkB50bESgJNhm3qtHHHepFJ9I3rAI130_provenance.